Skip to main content
Clinical Trials/CTRI/2022/10/046903
CTRI/2022/10/046903Not yet recruitingPhase 3

In vivo and Clinical Study To Evaluate The Efficacy Of Katakakhadiradi Ghana Vati Tiktaka Ghrita Tarpan In Pramehajanya Timira With Special Reference To Non Proliferative Diabetic Retinopathy A Randomized Controlled Trial

ational Institute of Ayurveda Jaipur0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Patients in the age group of 20 to 70 years
  • 2.Known cases of Type I and Type II diabetes mellitus with 5years of history
  • 3.Patients with well controlled blood sugar level
  • 4.Patients with visual symptoms like blurring of vision, floaters etc
  • 5.Patients with mild to moderate NPDR
  • 6.Patients willing to give written consent

Exclusion Criteria

  • 1.Patients with severe NPDR or with PDR, Diabetic Maculopathy.
  • 2.Patients with Diabetic Retinopathy with complications like Retinal detachment, posterior vitreal detachment, acute vitrealhemorrhage, Rubiosis Iridis.
  • 3.Gestational Diabetic Retinopathy.
  • 4.Severe visual impairments like high Myopia, Retinitis Pigmentosa, Mature Cataract, post Cataract surgeries, Glaucoma.
  • 5.Patients with other systemic complaints like Hypertension, Renal impairment, COPD, cardiovascular diseases.

Investigators

Sponsor
ational Institute of Ayurveda Jaipur

Similar Trials

Effect of Ayurvedic Eye Treatment in... | Clinical Trial